Ident. | Authors (with country if any) | Title |
---|
000123 |
Anthony H V. Schapira [Royaume-Uni] ; Susan H. Fox [Canada] ; Robert A. Hauser ; Joseph Jankovic [États-Unis] ; Wolfgang H. Jost [Allemagne] ; Christopher Kenney [États-Unis] ; Jaime Kulisevsky [Espagne] ; Rajesh Pahwa ; Werner Poewe [Autriche] ; Ravi Anand [Suisse] | Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial. |
000224 |
Anna Chang [Canada] ; Susan H. Fox [Canada] | Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management. |
000267 |
Maria Eliza Freitas [Canada] ; Susan H. Fox [Canada] | Nondopaminergic treatments for Parkinson's disease: current and future prospects. |
000410 |
Scott A. Norris [États-Unis] ; H A Jinnah [États-Unis] ; Alberto J. Espay [États-Unis] ; Christine Klein [Allemagne] ; Norbert Brüggemann [Allemagne] ; Richard L. Barbano [États-Unis] ; Irene Andonia C. Malaty [États-Unis] ; Ramon L. Rodriguez [États-Unis] ; Marie Vidailhet [France] ; Emmanuel Roze [France] ; Stephen G. Reich [États-Unis] ; Brian D. Berman [États-Unis] ; Mark S. Ledoux [États-Unis] ; Sarah Pirio Richardson [États-Unis] ; Pinky Agarwal [États-Unis] ; Zoltan Mari [États-Unis] ; William G. Ondo [États-Unis] ; Ludy C. Shih [États-Unis] ; Susan H. Fox [Canada] ; Alfredo Berardelli [Italie] ; Claudia M. Testa [États-Unis] ; Florence Ching-Fen Cheng [Australie] ; Daniel Truong [États-Unis] ; Fatta B. Nahab [États-Unis] ; Tao Xie [États-Unis] ; Mark Hallett [États-Unis] ; Ami R. Rosen [États-Unis] ; Laura J. Wright [États-Unis] ; Joel S. Perlmutter [États-Unis] | Clinical and demographic characteristics related to onset site and spread of cervical dystonia. |
000522 |
Tom M. Johnston [Canada] ; Susan H. Fox | Symptomatic Models of Parkinson's Disease and L-DOPA-Induced Dyskinesia in Non-human Primates. |
000582 |
Kaviraja Udupa [Canada] ; Susan H. Fox [Canada] | Placebo effect in Parkinson's disease: Harnessing the mind in the treatment of PD. |
000770 |
Cynthia L. Comella [États-Unis] ; Susan H. Fox [Canada] ; Kailash P. Bhatia [Royaume-Uni] ; Joel S. Perlmutter [États-Unis] ; Hyder A. Jinnah [États-Unis] ; Mateusz Zurowski [Canada] ; William M. Mcdonald [États-Unis] ; Laura Marsh [États-Unis] ; Ami R. Rosen [États-Unis] ; Tracy Waliczek [États-Unis] ; Laura J. Wright [États-Unis] ; Wendy R. Galpern [États-Unis] ; Glenn T. Stebbins [États-Unis] | Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology |
000794 |
Camila Catherine Aquino [Canada] ; Susan H. Fox | Clinical spectrum of levodopa-induced complications. |
000927 |
Ai Huey Tan [Malaisie] ; Sanjiv Mahadeva [Malaisie] ; Abdul Malik Thalha [Malaisie] ; Peter R. Gibson [Australie] ; Chiun Khang Kiew [Malaisie] ; Chia Ming Yeat [Malaisie] ; Sheang Wen Ng [Malaisie] ; Sheau Phing Ang [Malaisie] ; Siew Kian Chow [Malaisie] ; Chong Tin Tan [Malaisie] ; Hoi Sen Yong [Malaisie] ; Connie Marras [Canada] ; Susan H. Fox [Canada] ; Shen-Yang Lim [Malaisie] | Small intestinal bacterial overgrowth in Parkinson's disease. |
000C31 |
Barbara Connolly [Canada] ; Susan H. Fox [Canada] | Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson’s Disease |
000D19 |
Susan H. Fox [Canada] | Non-dopaminergic treatments for motor control in Parkinson's disease. |
000E81 |
Tiago A. Mestre [Canada] ; Mateusz Zurowski ; Susan H. Fox | 5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders. |
000E88 |
Lorraine V. Kalia [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials |
001036 |
Philippe Huot [Canada] ; Susan H. Fox [Canada] | The serotonergic system in motor and non-motor manifestations of Parkinson's disease |
001057 |
Susan H. Fox [Canada] | Non-dopaminergic Treatments for Motor Control in Parkinson's Disease |
001249 |
Barbara S. Connolly [Canada] ; Susan H. Fox | Drug treatments for the neuropsychiatric complications of Parkinson's disease. |
001413 |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Tayyeba Darr [Canada] ; Donna Pires [Canada] ; Lili-Naz Hazrati [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Increased levels of 5‐HT1A receptor binding in ventral visual pathways in Parkinson's disease |
001477 |
Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Qin Li [République populaire de Chine] ; Jonathan Brotchie [Canada] ; Erwan Bezard [République populaire de Chine, France] | A critique of available scales and presentation of the non‐human primate dyskinesia rating scale |
001824 |
Arpan R. Mehta [Canada, Royaume-Uni] ; Susan H. Fox [Canada] ; Mark Tarnopolsky [Canada] ; Grace Yoon [Canada] | Mitochondrial mimicry of multiple system atrophy of the cerebellar subtype |
001986 |
Susan H. Fox [Canada] ; Jonathan M. Brotchie | The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future. |
001B23 |
Pettarusp M. Wadia [Canada] ; Gamaliel Tan [Canada] ; Renato P. Munhoz [Canada] ; Susan H. Fox [Canada] ; Stephen J. Lewis [Canada] ; Anthony E. Lang [Canada] | Surgical correction of kyphosis in patients with camptocormia due to Parkinson's disease: a retrospective evaluation |
001C09 |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Tayyeba Darr [Canada] ; Lili-Naz Hazrati [Canada] ; Naomi P. Visanji [Canada] ; Donna Pires [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Increased 5‐HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations |
001C83 |
Benedicte Ballanger [États-Unis] ; Antonio P. Strafella [États-Unis, Canada] ; Thilo Van Eimeren [États-Unis] ; Mateusz Zurowski [États-Unis] ; Pablo M. Rusjan [États-Unis] ; Sylvain Houle [États-Unis] ; Susan H. Fox [États-Unis] | Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease |
001C89 |
Susan H. Fox [Canada] ; Naomi Visanji [Canada] ; Gaby Reyes [Canada] ; Philippe Huot [Canada] ; Jordi Gomez-Ramirez [Canada] ; Tom Johnston [Canada] ; Jonathan M. Brotchie [Canada] | Neuropsychiatric Behaviors in the MPTP Marmoset Model of Parkinson's Disease |
001D05 |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Tayyeba Darr [Canada] ; Lili-Naz Hazrati [Canada] ; Naomi P. Visanji [Canada] ; Donna Pires [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Increased 5-HT2A Receptors in the Temporal Cortex of Parkinsonian Patients with Visual Hallucinations |
001F59 |
Susan H. Fox [Canada] ; Rosalind Chuang [Canada] ; Jonathan M. Brotchie [Canada] | Serotonin and Parkinson's disease: On movement, mood, and madness |
002158 |
Susan H. Fox [Canada] ; Rosalind Chuang ; Jonathan M. Brotchie | Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy. |
002166 |
Susan H. Fox [Canada] ; Jonathan M. Brotchie ; Anthony E. Lang | Non-dopaminergic treatments in development for Parkinson's disease. |
002308 |
Susan H. Fox [Canada] ; Anthony E. Lang [Canada] | Levodopa‐related motor complications—Phenomenology |
002373 |
Naomi P. Visanji [Canada] ; Rob M. A. De Bie [Canada] ; Tom H. Johnston [Canada] ; Andrew C. Mccreary [Pays-Bas] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | The Nociceptin/Orphanin FQ (NOP) Receptor Antagonist J-113397 Enhances the Effects of Levodopa in the MPTP-Lesioned Nonhuman Primate Model of Parkinson's Disease |
002419 |
Cindy Zadikoff [États-Unis, Canada] ; Susan H. Fox [Canada] ; David F. Tang-Wai [Canada] ; Teri Thomsen [Canada] ; Rob M. A. De Bie [Canada, Pays-Bas] ; Pettarusup Wadia [Canada] ; Janis Miyasaki [Canada] ; Sarah Duff-Canning [Canada] ; Anthony E. Lang [Canada] ; Connie Marras [Canada] | A Comparison of the Mini Mental State Exam to the Montreal Cognitive Assessment in Identifying Cognitive Deficits in Parkinson's Disease |
002671 |
Teri R. Thomsen [Canada] ; Wendy R. Galpem [Canada] ; Abena Asante [Canada] ; Tamara Arenovich [Canada] ; Susan H. Fox [Canada] | Ipratropium Bromide Spray as Treatment for Sialorrhea in Parkinson's Disease |
002813 |
Naomi P. Visanji [Canada] ; Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Donna Pires [Canada] ; Valerie Voon [Canada, États-Unis] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Pharmacological characterization of psychosis‐like behavior in the MPTP‐lesioned nonhuman primate model of Parkinson's disease |
002B51 |
Tom H. Johnston [Canada] ; Joohyung Lee [Canada] ; Jordi Gomez-Ramirez [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] | A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease |